CompletedNCT01342939

Pathophysiological Implications of the Incretin Hormones in Maturity Onset of Diabetes of the Young (MODY)

Studying MODY

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Gentofte, Copenhagen
Principal Investigator
Signe H Østoft, MD, phd stud
Diabetes Research Division, University Hospital Gentofte, Denmark
Intervention
Oral Glucose Tolerance Test (OGTT)(other)
Enrollment
31 target
Eligibility
18 years · All sexes
Timeline
20112011

Study locations (1)

Collaborators

University of Copenhagen · Steno Diabetes Center Copenhagen

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01342939 on ClinicalTrials.gov

Other trials for MODY

Additional recruiting or active studies for the same condition.

See all trials for MODY

← Back to all trials